ITM, DCB sign agreement for Targeted Radionuclide Therapy
Korea | News | 0 Comment | 02 Sep, 2019
ITM Isotopen Technologien München AG (ITM), a biotechnology and radiopharmaceutical group of companies, and DuChemB...Read more
Agilent Presents Thought Leader Award to Professor Hyun Joo An
Korea | News | 0 Comment | 29 Aug, 2019
-Agilent Technologies has announced that Professor Hyun Joo An has received an Agilent Thought Leader Award in support o...Read more
Voronoi selects CDD Vault platform to manage Drug Discovery Data
Korea | News | 0 Comment | 23 Aug, 2019
Voronoi, drug discovery and development biotech company in Korea has announced that it has, after an extensive evaluatio...Read more
Gencurix's study explores GenesWell BCT and Oncotype DX differences
Korea | News | 0 Comment | 23 Aug, 2019
Gencurix, Inc., a molecular diagnostics company, announced the publication of a new study on Frontiers in Oncology&...Read more
Sustainable manufacturing practices to combat growing AMR
Korea | News | 0 Comment | 20 Aug, 2019
Centrient Pharmaceuticals, a global leader in sustainable antibiotics manufacturing, in partnership with Indian Institut...Read more
NOAC treatment effective against liver disease-associated atrial fibrillation
Korea | News | 0 Comment | 20 Aug, 2019
Researchers at Seoul National University Hospital have found that non-vitamin K oral anticoagulant (NOAC) is effective i...Read more
IDF Congress to bring together global diabetes community
Korea | News | 0 Comment | 20 Aug, 2019
The International Diabetes Federation (IDF) Congress is bringing together the global diabetes community to tackle a broa...Read more
KT Corp. unveils Global Epidemic Prevention Platform outside Korea
Korea | News | 0 Comment | 19 Aug, 2019
KT Corp. said its Global Epidemic Prevention Platform (GEPP) started service in Ghana on 14th, the first such ...Read more
Straumann Group to expand Warantec dental implants biz
Korea | News | 0 Comment | 14 Aug, 2019
Headquartered in Switzerland, The Straumann Group has entered into a partnership with Yuhan Corporation, Korea’s l...Read more
Samsung BioLogics implements N-1 perfusion for commercial application
Korea | News | 0 Comment | 13 Aug, 2019
Samsung BioLogics (SBL) has successfully performed N-1 (3,000L) perfusion with Alternating Tangential Flow (ATF) device ...Read more
Gencurix reveals new study for early stage breast cancer
Korea | News | 0 Comment | 13 Aug, 2019
Gencurix, Inc., a Korea based company dedicated in development and market of innovative molecular diagnostics, has annou...Read more
South Korea’s pharma-biotech space to attract foreign investment
Korea | News | 0 Comment | 08 Aug, 2019
South Korea’s plans to invest more than US$1.7bn in its biotechnology and biopharmaceutical sectors over the next ...Read more
SillaJen to discontinue PHOCUS trial for advanced liver cancer
Korea | News | 0 Comment | 06 Aug, 2019
SillaJen, Inc., a South Korea based clinical-stage, biotherapeutics company focused on the development of oncolytic immu...Read more
Drive for generics sees Korea increasingly attractive to international pharma
Korea | News | 0 Comment | 02 Aug, 2019
Already home to more than 40 pharmaceutical multinationals, Korea is on course to become a global biotech and pharmaceut...Read more
Samsung BioLogics, UCB sign third drug manufacturing deal
Korea | News | 0 Comment | 01 Aug, 2019
South Korea headquartered Samsung BioLogics (SBL) and Belgium based biopharmaceutical company UCB have agreed to an addi...Read more
Mezzion Pharma announces positive results from FUEL trial
Korea | News | 0 Comment | 31 Jul, 2019
Mezzion Pharma Co. Ltd., a biotech company based in Korea, haas announced that top line data from the Phase 3 Fonta...Read more
LISCure Biosciences completes seed funding of $5M
Korea | News | 0 Comment | 26 Jul, 2019
LISCure Biosciences, a South Korea based biotech company that researches and develops bacteria-mediated immunotherapy, h...Read more
FDA approves arthritis drug by Samsung Bioepis
Korea | News | 0 Comment | 24 Jul, 2019
Samsung Bioepis becomes the first company to receive FDA approvals for biosimilars referencing all three first-generatio...Read more